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Objective.The aim of the study was to evaluate the effects of a 28-day exposure to a 50Hz electromagnetic field of 10 kV/m on the
oxidative stress in selected rat central nervous system (CNS) structures. Material and Methods. Twenty male Wistar rats served as
experimental subjects. Ten rats were exposed to an electromagnetic field with a frequency of 50Hz, intensity of 10 kV/m, and
magnetic induction of 4.3 pT for 22 hours a day. The control group of ten rats was subject to sham exposure. Homogenates of
the frontal cortex, hippocampus, brainstem, hypothalamus, striatum, and cerebellum were evaluated for selected parameters of
oxidative stress. Results. Following the four-week exposure to a low-frequency electromagnetic field, the mean malondialdehyde
levels and total oxidant status of CNS structures did not differ significantly between the experimental and control groups.
However, the activities of antioxidant enzymes in brain structure homogenates were decreased except for frontal cortex catalase,
glutathione peroxidase, and hippocampal glutathione reductase. The low-frequency electromagnetic field had no effect on the
nonenzymatic antioxidant system of the examined brain structures except for the frontal cortex. Conclusion. The four-week
exposure of male rats to a low-frequency electromagnetic field did not affect oxidative stress in the investigated brain structures.
1. Introduction
An electromagnetic field (EMF) occurs naturally in our
environment. It is generated by geological structures in the
Earth’s crust, and all devices powered with alternating cur-
rents. Multihour use of such devices, including medical appa-
ratus, results in a prolonged exposure to a low-frequency
EMF (≤50Hz). This may lead to disturbances in homeostasis
and consequent disruption of the prooxidative-antioxidative
balance within the central nervous system (CNS) of people
permanently working in close proximity to devices generat-
ing electromagnetic fields [1].
In the last decade, the effects of a low-frequency electro-
magnetic field (LFEMF) on the human body have been
referred to as electromagnetic sensitivity syndrome com-
monly associated with the rapid development of wireless
technologies [2, 3]. The molecular mechanisms of nonther-
mal and nonionizing effects at low field intensities remain
to be elucidated. Nevertheless, the number of research studies
on this issue continues to grow [4–6]. A wide range of health
problems associated with exposure to computer monitors,
mobile phones, and other EMF-generating appliances has
been reported. The most common symptoms include fatigue,
irritation, headache, dryness of the skin and mucous mem-
branes, sleep disturbance, and hormonal imbalance as well
as cardiac and neural effects [7, 8]. Exposure to an EMF has
also been linked with allergic reactions confirmed by a
marked increase in the number of mast cells [9]. Numerous
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epidemiological studies have confirmed a significant increase
in the risk of brain tumours [10, 11], parotid gland tumours
[12], malignant melanoma [13], and lymphomas [14].
Several researchers have emphasised that exposure to the
EMF might also cause increased reactive oxygen species
(ROS) production and lead to oxidative stress [2, 15]. ROS
have been implicated in the pathogenesis of neurodegenera-
tive diseases including Alzheimer’s disease, multiple sclero-
sis, or amyotrophic lateral sclerosis [16, 17]. It has also
been found that oxidative stress might be involved in the
development of Parkinson’s disease [18, 19] and in the path-
ogenesis of mental disorders [20, 21]. Despite differences in
the clinical features of neurodegenerative diseases, it has
been suggested that they share common mechanisms such
as dysregulation of iron metabolism, protein aggregation,
oxidative stress, inflammatory processes, and mitochondrial
dysfunction. However, all these phenomena have so far been
studied separately without considering possible interactions
or an option that they might occur as cascading events. Nev-
ertheless, oxidative stress has been mentioned as the primary
cause of neural cell damage [22].
The effect of the LFEMF on the prooxidative-antioxidative
balance in CNS structures is yet to be extensively studied.
Furthermore, only whole brain homogenates from experimen-
tal animals were evaluated. No assessment was carried out
regarding particular brain structures, markers of oxidative
stress, or activity of enzymatic and nonenzymatic antioxidant
systems. Such incomplete analysis severely hinders the inter-
pretation of results.
Therefore, the aim of this study was to evaluate the effects
of a 28-day exposure to a 50Hz electromagnetic field of
10 kV/m on the oxidative stress in selected CNS structures
(frontal cortex, hippocampus, brainstem, hypothalamus,
striatum, and cerebellum) of male rats.
2. Material and Methods
2.1. Animals. The study was performed with the approval
no. 65/2008 of the Bioethical Committee for Animal Experi-
mentation of the Medical University of Silesia in Katowice,
Poland. All animals received humane care in compliance
with the 8th edition of the Guide for the Care and Use of
Laboratory Animals published by the National Institute
of Health [23].
Twenty male Wistar rats aged 10 weeks and weighing
approximately 280 grams served as the experimental sub-
jects. The animals were bred at the Institute of Experimental
Medicine, Medical University of Silesia in Katowice Ligota,
Poland. During the experiment, the rats were kept under
optimal environmental conditions, i.e., at a temperature
of 21°C and constant humidity, maintaining their 24-hour
circadian rhythm. They were housed 10 per cage in plastic
cages and fed with standard laboratory pellet food (Labofed
B) and water at libitum.
2.2. Experimental Model. The rats were randomly divided
into four groups, consisting of 10 animals each. Group A
was exposed daily to an electromagnetic field with a fre-
quency of 50Hz, intensity of 10 kV/m, and magnetic
induction of 4.3 pT. Exposure duration was 22 hours per
day (with a break between 08 : 00 and 10 : 00). During the
exposure, the animals remained in a plastic cage positioned
between two electrodes placed 50 centimeters apart. The
plastic cage did not impede the electromagnetic field and
allowed the free movement of the rats. One electrode received
a potential of 5 kV from a high-voltage transformer. The cage
housing the rats was placed on the ground electrode. The
control group of ten rats (group C) were subject to sham
exposure (22 hours a day). Rats from group M were
exposed for 28 successive days to an electromagnetic field
with a frequency of 900MHz generated by a mobile phone.
Rats from group A+M were exposed, for 28 successive days,
simultaneously to both a 50Hz electromagnetic field and a
radio-frequency electromagnetic field generated by a mobile
phone. The physical parameters and duration of exposure
were identical to those described for group A and group M.
In this manuscript, we have only presented the findings
from group A and the control group.
Following the cycle of a 28-day exposure to an electro-
magnetic field and sham exposure, the rats were fasted for
24 hours and euthanized and the brains were removed. The
dissection of brain structures was carried out by a person
experienced in rat dissection. After decapitation and opening
the skull, the brain was removed and the following structures
were dissected: frontal cortex, striatum, hippocampus, hypo-
thalamus, and cerebellum. For identifying brain structures,
sections were systematically compared with images from
the adult rat brain atlas [24]. The sampled tissues were frozen
in solid carbon dioxide (dry ice), weighed, and kept deep-
frozen at -70°C.
2.3. Preparation of Brain Tissue Homogenates. On the day
of laboratory determinations, the tissues were homogenized
for 3 minutes at 50 revolutions per minute using the Glas-
Col Tissue Homogenizing System at a room temperature
of 21°C. The tissues were homogenized in physiological
buffered saline. The following were then determined in
the obtained 5% tissue homogenates: total oxidant status
(TOS), malondialdehyde (MDA), superoxide dismutase
(SOD) and its isoenzymes (copper-zinc dismutase (SOD-
CuZn), manganese dismutase (SOD-Mn)), catalase (CAT),
glutathione peroxidase (GPx), glutathione reductase (GR),
glutathione S-transferase (GST), and total antioxidant capac-
ity (TAC).
2.4. Biochemical Analysis
2.4.1. Oxidative Stress Marker Analysis
(1) Determination of Prooxidative Status Parameters: Lipid
Peroxidation Products and Total Oxidative Status. The inten-
sity of lipid peroxidation in the brain homogenates was
measured spectrofluorimetrically as thiobarbituric acid-
reactive substances (TBARS) according to Ohkawa et al.
[25]. The TBARS concentrations were expressed as malon-
dialdehyde (MDA) equivalents in μmol/g protein. The inter-
and intra-assay coefficients of variations (CV) were 2.2% and
8.4%, respectively.
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The total oxidant status (TOS) was determined with the
method described by Erel [26] and expressed in μmol/g pro-
tein. The inter- and intra-assay coefficients of variations (CV)
were 2.1% and 6.3%, respectively.
(2) Determination of the Activity of Antioxidant Enzymes.
The superoxide dismutase (SOD-E.C.1.15.1.1) activity in
brain homogenates was assayed using the Oyanagui method
[27]. Enzymatic activity was expressed in nitrite unit (NU) in
each mg of hemoglobin (Hb) or ml of blood plasma. One
nitrite unit (1 NU) means a 50% inhibition of nitrite ion pro-
duction by SOD in this method. SOD isoenzymes (SOD-Mn
and SOD-CuZn) were measured using potassium cyanide as
the inhibitor of the SOD-ZnCu isoenzyme. The inter- and
intra-assay coefficients of variations (CV) were 2.8% and
5.4%, respectively.
Catalase (CAT-E.C.1.11.1.6.) activity was determined
with the peroxide-purpald method developed by Johansson
and Håkan Borg [28]. The method is based on the reaction
of catalase with methanol in the presence of an optimal con-
centration of hydrogen peroxide. The obtained formaldehyde
is measured spectrophotometrically at 550nm with Pur-
pald as a chromogen. The enzymatic activity of catalase was
expressed in IU/g of protein. The inter- and intra-assay coeffi-
cients of variations (CV) were 2.6% and 6.1%, respectively.
The activity of brain homogenates’ glutathione perox-
idase (GPx-E.C.1.11.1.9.) was assayed using Paglia and
Valentine’s kinetic method [29], with t-butyl peroxide as a
substrate and expressed as micromoles of NADPH oxidized
per minute and normalised to one gram of protein [IU/g pro-
tein]. The inter- and intra-assay coefficients of variations
(CV) were 3.3% and 7.4%, respectively.
The glutathione reductase activity (GR-E.C.1.6.4.2) in
brain homogenates was assayed using Richterich’s kinetic
method [30], expressed as micromoles of NADPH utilized
per minute, and normalised to one gram of protein [IU/g
protein]. The inter- and intra-assay coefficients of variations
(CV) were 2.2% and 5.7%, respectively.
The activity of glutathione S-transferase (GST-
E.C.2.5.1.18) was determined with the kinetic method of
Habig and Jakoby [31], expressed as micromoles of thioether
formed per minute and normalised to one gram of protein
[IU/g protein]. The inter- and intra-assay coefficients of var-
iations (CV) were 3.4% and 7.3%, respectively.
(3) Determination of Nonenzymatic Antioxidant Status.
Total antioxidant capacity (TAC) concentration in brain
structure homogenates was determined with the method of
Erel [32] based on oxidized ABTS (green in colour) decolor-
isation by antioxidants present in the sample and calibrated
using Trolox and expressed in mmol/g protein. The inter-
and intra-assay coefficients of variations (CV) were 1.1%
and 3.8%, respectively.
2.5. Statistical Analysis. The obtained results were pre-
sented as the mean ± standard deviation (M± SD) and
analyzed using Statistica 7.1 PL software. All parameters
of the group exposed to the electromagnetic field were
compared to sham-exposed animals (control group). The
Shapiro-Wilk test was used to test for normality of the
distribution of particular variables. Intergroup differences
were examined using a single-factor parametric ANOVA
for quantitative variables. Additionally, the relationships
identified by the ANOVA were verified using the NIR post
hoc test for the particular groups. The level of statistical sig-
nificance (p < 0 05) was used in all analyses.
3. Results
3.1. Oxidative Stress Parameters in the Frontal Cortex. In the
frontal cortex homogenates from rats exposed to the LFEMF
(group A), the mean activities of SOD, SOD-Mn, GPx, GST,
and TOS were significantly lower, while the mean CAT activ-
ity was higher compared to the control rats (group C). How-
ever, the mean concentrations of MDA and TOS as well as
the mean activities of SOD-CuZn and GR in rats exposed
to the LFEMF did not differ significantly in comparison to
the control group (Table 1).
3.2. Oxidative Stress Parameters in the Hippocampus. In the
hippocampus homogenates from rats exposed to the low-
frequency electromagnetic field, the mean activity of GR
was significantly higher, while GST activity was significantly
lower in comparison to the control group. However, no sig-
nificant differences were observed between the mean MDA,
TOS, and TAC concentrations as well as the mean SOD,
SOD-Mn, SOD-CuZn, CAT, and GPx activities in rats
exposed to the low-frequency electromagnetic field com-
pared to the control group (Table 2).
3.3. Oxidative Stress Parameters in the Brainstem. In the
brainstem homogenates from rats exposed to the LFEMF,
the mean activities of SOD, SOD-Mn, SOD-CuZn, GR, and
GST were significantly lower in comparison to those of the
control rats. However, the mean MDA, TOS, and TAC con-
centrations as well as the mean CAT and GPx activities did
not differ significantly in rats exposed to the LFEMF in com-
parison to the control group (Table 3).
3.4. Oxidative Stress Parameters in the Hypothalamus. In
the hypothalamus homogenates from rats exposed to the
LFEMF, the mean activity of GST homogenates was signifi-
cantly higher compared to the control group. However, the
mean MDA, TOS, and TAC concentrations as well as the
mean SOD, SOD-Mn, SOD-CuZn, CAT, GPx, and GR activ-
ities in the hypothalamus homogenates from rats exposed to
the LFEMF did not differ significantly in comparison to the
sham-exposed rats (Table 4).
3.5. Oxidative Stress Parameters in the Striatum. In the stria-
tum homogenates from rats exposed to the LFEMF, the mean
activity of GST homogenates was significantly lower in com-
parison to the control group. The GST activity was the only
parameter whose values differed significantly between the
studied groups. However, the mean MDA, TOS, and TAC
concentrations as well as the mean SOD, SOD-Mn, SOD-
CuZn, CAT, GPx, and GR activities in the striatum homoge-
nates from rats exposed to the LFEMF did not differ signifi-
cantly in comparison to the sham-exposed rats (Table 5).
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3.6. Oxidative Stress Parameters in the Cerebellum. In the
cerebellum homogenates from rats exposed to the LFEMF,
only the mean activity of GST homogenates was signifi-
cantly lower in comparison to the control group. However,
the mean MDA, TOS, and TAC concentrations as well as
the mean SOD, SOD-Mn, SOD-CuZn, CAT, GPx, and GR
activities in the group of rats exposed to the LFEMF did not
differ significantly in comparison to the sham-exposed rats
(Table 6).
4. Discussion
It has been found that the electromagnetic field may disrupt
the prooxidative-antioxidative balance through increased
ROS production, impaired ROS elimination, or the com-
bined effect of both processes [33, 34]. Hence, the evaluation
of oxidative stress severity must comprise the determination
of oxidative stress markers as well as the activity of the
enzymatic and nonenzymatic antioxidant systems simulta-
neously [35, 36].
Our study on the effects of a 4-week exposure of male
rats to the LFEMF did not reveal any statistically significant
differences in the mean MDA and TOS concentrations in
CNS structures between the rats exposed to the LFEMF and
sham-exposed animals. Hence, chronic exposure to the
low-frequency electromagnetic field does not seem to have
resulted in increased lipid peroxidation and ROS generation
in the rat brain.
In the frontal cortex of rats exposed to the LFEMF, the
mean activities of SOD and SOD-Mn homogenates were
lower by 13.1% and 15.1%, respectively, compared to the
control group. In addition, the mean activities of SOD,
SOD-Mn, and SOD-CuZn in the brainstem of rats exposed
to the LFEMF were lower by 16.5%, 15.9%, and 17.1%,
Table 1: Concentrations of oxidative stress biomarkers: malondialdehyde (MDA) and total oxidant status (TOS); activity of antioxidant
enzymes: superoxide dismutase (SOD) and isoenzymes (SOD-Mn, SOD-CuZn), catalase (CAT), glutathione peroxidase (GPx), glutathione
reductase (GR), and glutathione S-transferase (GST); and concentration of nonenzymatic antioxidants—total antioxidant capacity (TAC)
in the frontal cortex homogenates from rats exposed to low-frequency electromagnetic field (group A) and sham-exposed rats (control
group) (group C) with results of ANOVA for all examined groups (A, C, M, and A+M) and post hoc NIR test for two selected groups: A
and C.
Group A Group C ANOVA results
Parameter M± SD M± SD F; p value p value of NIR test
MDA concentration (μmol/g protein) 1.12± 0.09 1.04± 0.16 9.68; <0.001 0.538
TOS concentration (μmol/g protein) 2.17± 0.35 2.10± 0.39 0.6; 0.622 0.623
SOD activity (NU/mg protein) 49.38± 5.85 56.80± 3.25 13.02; <0.001 <0.001
SOD-Mn activity (NU/mg protein) 29.75± 3.12 35.05± 2.53 13.02; <0.001 <0.001
SOD-CuZn activity (NU/mg protein) 19.63± 4.45 21.75± 2.19 2.82; 0.040 0.219
CAT activity (IU/g protein) 6.16± 0.92 3.48± 1.05 17.66; <0.001 <0.001
GPx activity (IU/g protein) 0.59± 0.09 0.77± 0.13 3.87; 0.017 <0.01
GR activity (IU/g protein) 18.96± 1.98 19.91± 1.28 14.81; <0.001 0.097
GST activity (IU/g protein) 2.03± 0.21 2.99± 0.21 47.03; <0.001 <0.01
TAC concentration (mmol/g protein) 0.06± 0.00 0.07± 0.01 3.34; 0.031 <0.01
Table 2: Concentrations of oxidative stress biomarkers: malondialdehyde (MDA) and total oxidant status (TOS); activity of antioxidant
enzymes: superoxide dismutase (SOD) and isoenzymes (SOD-Mn, SOD-CuZn), catalase (CAT), glutathione peroxidase (GPx), glutathione
reductase (GR), and glutathione S-transferase (GST); and concentration of nonenzymatic antioxidants—total antioxidant capacity (TAC)
in the hippocampus homogenates from rats exposed to low-frequency electromagnetic field (group A) and sham-exposed rats (control
group) (group C) with results of ANOVA for all examined groups (A, C, M, and A+M) and post hoc NIR test for two selected groups: A
and C.
Group A Group C ANOVA results
Parameter M± SD M± SD F; p value p value of NIR test
MDA concentration (μmol/g protein) 1.79± 0.48 1.56± 0.34 1.86; 0.156 0.294
TOS concentration (μmol/g protein) 2.68± 0.43 2.36± 0.23 1.50; 0.232 0.081
SOD activity (NU/mg protein) 70.73± 9.09 65.78± 6.63 8.78; 0.035 1.000
SOD-Mn activity (NU/mg protein) 38.75± 3.87 37.05± 3.02 13.66; <0.001 0.278
SOD-CuZn activity (NU/mg protein) 31.98± 6.64 28.73± 6.37 1.06; 0.379 0.212
CAT activity (IU/g protein) 5.02± 0.78 5.79± 0.76 14.40; <0.001 0.084
GPx activity (IU/g protein) 0.45± 0.19 0.47± 0.13 0.20; 0.898 0.848
GR activity (IU/g protein) 30.56± 3.34 26.97± 2.19 11.56; <0.001 <0.01
GST activity (IU/g protein) 3.92± 0.37 4.57± 0.28 6.96; <0.001 <0.01
TAC concentration (mmol/g protein) 0.10± 0.01 0.09± 0.01 0.38; 0.765 0.612
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respectively, in comparison to the control group. However,
the mean SOD activity in the hippocampus, hypothalamus,
striatum, and cerebellum in rats exposed to the LFEMF did
not differ significantly in comparison to the control group.
The mean CAT activity in the rats exposed to the LFEMF
was only significantly higher by 77% in the frontal cortex
compared to the control group. No significant differences
in the mean CAT activity were found between the rats
exposed to the LFEMF and the control group with respect
to the examined remaining brain structures. In addition,
the GPx activity in rats exposed to the LFEMF was lower by
23.6% than that of the control rats, but again, only in the
frontal cortex. In the remaining examined brain structures,
the GPx activity in rats exposed to the LFEMF did not differ
significantly when compared to the control group. The mean
GR activity in the rats exposed to the LFEMF was higher by
13.3% in the hippocampus, while in the brainstem its activity
was lower by 25.1% in comparison to the control group. No
significant differences in GR activity were found between
the rats exposed to the LFEMF and the control group with
respect to the remaining investigated brain structures. GST
activity in rats exposed to the LFEMF was significantly lower
in all investigated brain structures: in the frontal cortex
by 32%, in the hippocampus by 14.2%, in the brainstem by
31.7%, in the hypothalamus by 23.2%, in the striatum by
11.5%, and in the cerebellum by 18.2% compared to the con-
trol group. Similarly, in our study, the mean TAC concentra-
tions in the rats exposed to the LFEMF were lower by 13.4%
in comparison to the control group, but only in the frontal
cortex. No significant differences in TAC concentrations
Table 3: Concentrations of oxidative stress biomarkers: malondialdehyde (MDA) and total oxidant status (TOS); activity of antioxidant
enzymes: superoxide dismutase (SOD) and isoenzymes (SOD-Mn, SOD-CuZn), catalase (CAT), glutathione peroxidase (GPx), glutathione
reductase (GR), and glutathione S-transferase (GST); and concentration of nonenzymatic antioxidants—total antioxidant capacity (TAC)
in the brainstem homogenates from rats exposed to low-frequency electromagnetic field (group A) and sham-exposed rats (control group)
(group C) with results of ANOVA for all examined groups (A, C, M, and A+M) and post hoc NIR test for two selected groups: A and C.
Group A Group C ANOVA results
Parameter M± SD M± SD F; p value p value of NIR test
MDA concentration (μmol/g protein) 1.93± 0.46 2.60± 0.38 3.12; 0.020 0.568
TOS concentration (μmol/g protein) 4.04± 1.25 3.19± 1.36 1.14; 0.349 0.217
SOD activity (NU/mg protein) 120.63± 5.58 144.45± 9.87 16.81; <0.001 <0.001
SOD-Mn activity (NU/mg protein) 63.79± 4.43 75.84± 6.37 14.76; <0.001 <0.01
SOD-CuZn activity (NU/mg protein) 56.84± 4.05 68.61± 8.48 17.26; <0.001 <0.01
CAT activity (IU/g protein) 11.64± 1.40 12.81± 1.10 14.26; <0.01 0.932
GPx activity (IU/g protein) 1.14± 0.31 1.38± 0.17 1.72; 0.181 0.103
GR activity (IU/g protein) 21.68± 1.55 28.95± 1.24 38.32; <0.001 <0.001
GST activity (IU/g protein) 3.77± 0.25 5.52± 0.54 34.71; <0.001 <0.001
TAC concentration (mmol/g protein) 0.12± 0.02 0.11± 0.04 0.57; 0.636 0.304
Table 4: Concentrations of oxidative stress biomarkers: malondialdehyde (MDA) and total oxidant status (TOS); activity of antioxidant
enzymes: superoxide dismutase (SOD) and isoenzymes (SOD-Mn, SOD-CuZn), catalase (CAT), glutathione peroxidase (GPx), glutathione
reductase (GR), and glutathione S-transferase (GST); and concentration of nonenzymatic antioxidants—total antioxidant capacity (TAC)
in the hypothalamus homogenates from rats exposed to low-frequency electromagnetic field (group A) and sham-exposed rats (control
group) (group C) with results of ANOVA for all examined groups (A, C, M, and A+M) and post hoc NIR test for two selected groups: A
and C.
Group A Group C ANOVA results
Parameter M± SD M± SD F; p value p value of NIR test
MDA concentration (μmol/g protein) 1.03± 0.15 0.76± 0.13 11.76; <0.001 0.079
TOS concentration (μmol/g protein) 2.85± 0.51 2.68± 0.35 1.37; 0.268 0.535
SOD activity (NU/mg protein) 72.00± 12.56 82.99± 7.58 1.40; 0.260 0.064
SOD-Mn activity (NU/mg protein) 48.53± 5.67 52.41± 4.11 0.73; 0.543 0.263
SOD-CuZn activity (NU/mg protein) 23.46± 9.42 30.59± 3.76 6.48; 0.029 0.119
CAT activity (IU/g protein) 9.11± 2.78 8.80± 1.73 0.28; 0.841 0.800
GPx activity (IU/g protein) 0.47± 0.44 0.43± 0.30 0.54; 0.660 0.862
GR activity (IU/g protein) 23.91± 3.14 24.05± 2.22 2.69; 0.046 0.921
GST activity (IU/g protein) 4.86± 0.94 6.33± 0.49 11.18; <0.001 <0.001
TAC concentration (mmol/g protein) 0.09± 0.01 0.10± 0.01 1.03; 0.393 0.652
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were found between the rats exposed to the LFEMF and the
control group with respect to the remaining investigated
brain structures.
Different responses of oxidative stress parameters in
brain structures under investigation might have been caused
by the different impact of the LFEMF on these structures as
well as differences in their functions.
There are only a few reports available on the effects of the
LFEMF on prooxidative-antioxidative balance within the
central nervous system, but it should be noted that, due to a
high level of aerobic metabolism, large amounts of unsatu-
rated fatty acids, and lower antioxidant activity, neurons are
particularly vulnerable to disturbances in the prooxidative-
antioxidative balance [37, 38].
The available results of researches are not unequivo-
cal, which might be due to the differences in the physical
parameters of applied electromagnetic fields and different
methodologies of exposure. Jelenković et al. [39] are the only
investigators who have evaluated the effects of exposure to
the LFEMF on several brain structures in rats. However,
the nonenzymatic antioxidant system was not assessed, and
hence, no ultimate conclusions can be drawn regarding the
prooxidative-antioxidative balance. Also, the rats were
exposed to the LFEMF (50Hz, 0.5mT) for 7 days only.
Nevertheless, the production of superoxide anion radical
and MDA concentrations increased in all CNS-investigated
structures. A significant increase in nitric oxide production
was found in the frontal cortex and hypothalamus, while
higher SOD activity was only observed in the hypothalamus.
Akdag et al. [40] examined brain homogenates of rats
exposed to a 100 or 500μT electromagnetic field for 2 hours
a day for 10 months. The CAT activity decreased in both
Table 5: Concentrations of oxidative stress biomarkers: malondialdehyde (MDA) and total oxidant status (TOS); activity of antioxidant
enzymes: superoxide dismutase (SOD) and isoenzymes (SOD-Mn, SOD-CuZn), catalase (CAT), glutathione peroxidase (GPx), glutathione
reductase (GR), and glutathione S-transferase (GST); and concentration of nonenzymatic antioxidants—total antioxidant capacity (TAC)
in the striatum homogenates from rats exposed to low-frequency electromagnetic field (group A) and sham-exposed rats (control group)
(group C) with results of ANOVA for all examined groups (A, C, M, and A+M) and post hoc NIR test for two selected groups: A and C.
Group A Group C ANOVA results
Parameter M± SD M± SD F; p value p value of NIR test
MDA concentration (μmol/g protein) 1.02± 0.12 1.12± 0.26 1.86; 0.156 0.278
TOS concentration (μmol/g protein) 1.64± 0.99 1.75± 0.86 14.70; <0.01 1.000
SOD activity (NU/mg protein) 64.35± 15.38 64.16± 8.73 16.16; 0.201 1.000
SOD-Mn activity (NU/mg protein) 32.49± 3.87 32.78± 2.31 4.60; <0.01 0.487
SOD-CuZn activity (NU/mg protein) 31.86± 13.15 31.39± 8.29 1.13; 0.350 0.908
CAT activity (IU/g protein) 4.73± 2.12 3.79± 1.20 55.86;<0.001 0.277
GPx activity (IU/g protein) 1.15± 0.22 1.25± 0.15 6.16; <0.01 0.238
GR activity (IU/g protein) 25.92± 3.56 25.55± 2.76 21.42; <0.001 1.000
GST activity (IU/g protein) 2.93± 0.34 3.32± 0.19 6.63; <0.01 <0.01
TAC concentration (mmol/g protein) 0.08± 0.01 0.08± 0.01 0.36; 0.783 0.347
Table 6: Concentrations of oxidative stress biomarkers: malondialdehyde (MDA) and total oxidant status (TOS); activity of antioxidant
enzymes: superoxide dismutase (SOD) and isoenzymes (SOD-Mn, SOD-CuZn), catalase (CAT), glutathione peroxidase (GPx), glutathione
reductase (GR), and glutathione S-transferase (GST); and concentration of nonenzymatic antioxidants—total antioxidant capacity (TAC)
in the cerebellum homogenates from rats exposed to low-frequency electromagnetic field (group A) and sham-exposed rats (control
group) (group C) with results of ANOVA for all examined groups (A, C, M, and A+M) and post hoc NIR test for two selected groups: A
and C.
Group A Group C ANOVA results
Parameter M± SD M± SD F; p value p value of NIR test
MDA concentration (μmol/g protein) 3.30± 1.269 2.76± 0.79 13.73; <0.001 0.292
TOS concentration (μmol/g protein) 4.14± 0.58 4.40± 0.76 14.82; <0.01 1.000
SOD activity (NU/mg protein) 99.80± 16.56 94.77± 4.84 21.23; <0.01 1.000
SOD-Mn activity (NU/mg protein) 97.71± 14.55 92.05± 4.12 20.89; <0.001 1.000
SOD-CuZn activity (NU/mg protein) 2.28± 2.17 2.71± 1.21 17.86; <0.001 1.000
CAT activity (IU/g protein) 12.38± 3.42 9.74± 2.96 4.07; 0.014 0.129
GPx activity (IU/g protein) 1.88± 0.23 1.79± 0.23 13.01; <0.01 1.000
GR activity (IU/g protein) 19.08± 3.36 18.93± 1.11 15.62; <0.01 1.000
GST activity (IU/g protein) 2.93± 0.42 3.58± 0.53 18.39; <0.001 <0.01
TAC concentration (mmol/g protein) 0.07± 0.06 0.13± 0.01 20.32; <0.001 1.000
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exposure groups. The TAC concentration was lower in the
500μT group compared to the 100μT and sham-exposed
groups, while MDA, TOS concentration, and oxidative stress
index were higher.
Lee et al. [41] observed a significant increase in chemilu-
minescence and SOD activity in brain homogenates of mice
after a 3-hour exposure to a 60Hz electromagnetic field.
Falone et al. [42] showed that continuous 10-day expo-
sure to a 50Hz, 0.1mT EMF significantly affected the antiox-
idative capacity of the female rat brain, the effect being age-
dependent. The activity of antioxidant enzymes increased
in young and decreased in old animals. This observation
was supported by the results of Rageh et al. [43], who exposed
10-day-old rats to a continuous 50Hz, 0.5mT electromag-
netic field for 30 days. They found that EMF exposure
resulted in higher MDA concentration and SOD activity
and increased the rate of oxidative damage to cellular DNA.
It should be emphasized though that the above study was
performed using juvenile rats whose CNS had not been fully
developed yet.
Physical factors of limited intensity might also have some
beneficial effects in the form of adaptive process stimulation.
Ciejka et al. [44] observed that a longer exposure to a 7mT,
40Hz electromagnetic field apparently resulted in the adap-
tation to experimental conditions. An analysis of brain
homogenates of adult rats after a 60-minute daily exposure
to the electromagnetic field over a period of 10 days revealed
a significant increase in the sulfhydryl group and protein
concentration, while a 30-minute daily exposure caused a sig-
nificant increase in lipid peroxidation.
The exposure of our experimental rats to a 50Hz EMF
lasted for four weeks. Since human exposure to the EMF is
typically long-term, we did not aim to examine the effects
of short-term exposure. The issue is challenging and requires
further studies.
5. Conclusions
Summing up, it can be concluded that a four-week exposure
of male rats to the low-frequency electromagnetic field does
not affect oxidative stress in the studied brain structures.
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